MebeaAkliluMD

PubMed

• 99 citations
  Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer.
  Leigh C. Casadaban, Garth H. Rauscher, Mebea Aklilu, Dana Villenes, Sally Freels, Ajay V. Maker> ;Cancer. 2016 Nov 1
• 91 citations
  Outcomes of Patients With Esophageal Cancer Staged With [18F]Fluorodeoxyglucose Positron Emission Tomography (FDG-PET): Can Postchemoradiotherapy FDG-PET Predict the U...
  Arta M. Monjazeb, Greg Riedlinger, Mebea Aklilu, Kim R. Geisinger, Girish Mishra, Scott Isom, Paige B. Clark, Edward A. Levine, A. William Blackstock> ;Journal of Clinical Oncology. 2010 Nov 1
• 17 citations
  A brief yoga intervention implemented during chemotherapy: A randomized controlled pilot study.
  Stephanie J. Sohl, Suzanne C. Danhauer, Gurjeet S. Birdee, Barbara J. Nicklas, George Yacoub, Mebea Aklilu, Nancy E. Avis> ;Complementary Therapies in Medicine. 2016 Apr 1
• 3 citations
  Phase II Trial of Adjuvant Oral Thalidomide Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Disease from Colorecta...
  Perry Shen, Christopher R. Thomas, Joyce Fenstermaker, Mebea Aklilu, Thomas P. McCoy, Edward A. Levine> ;Journal of Gastrointestinal Cancer. 2014 Jan 23
• 86 citations
  A Randomized Phase II Study of Immunization With Dendritic Cells Modified With Poxvectors Encoding CEA and MUC1 Compared With the Same Poxvectors Plus GM-CSF for Resec...
  Michael A. Morse, Donna Niedzwiecki, John L. Marshall, Christopher R. Garrett, David Z. Chang, Mebea Aklilu, Todd S. Crocenzi, David J. Cole, Sophie Dessureault, Amy H...> ;Annals of Surgery. 2013 Dec 1
• 27 citations
  A randomized pilot phase I study of modified carcinoembryonic antigen (CEA) peptide (CAP1-6D)/montanide/GM-CSF-vaccine in patients with pancreatic adenocarcinoma
  Daniel M. Geynisman, Yuanyuan Zha, Rangesh Kunnavakkam, Mebea Aklilu, Daniel V.T. Catenacci, Blase N. Polite, Azadeh Namakydoust, Theodore Karrison, Thomas F. Gajewski...> ;Journal for Immunotherapy of Cancer. 2013 Jun 27
• 5 citations
  A two-cohort phase I study of weekly oxaliplatin and gemcitabine, then oxaliplatin, gemcitabine, and erlotinib during radiotherapy for unresectable pancreatic carcinoma.
  Laura Raftery, Joel E. Tepper, Richard M. Goldberg, A. William Blackstock, Mebea Aklilu, Stephen A. Bernard, Anastasia Ivanova, Janine M. Davies, Bert H. O’Neil> ;American Journal of Clinical Oncology. 2013 Jun 1
• 6 citations
  Optimal timing of systemic therapy in resectable colorectal liver metastases.
  Chukwuemeka Ihemelandu, Edward A. Levine, Mebea Aklilu, George Yacoub, Russell Howerton, Britt H. Bolemon, Matthew Graham, Greg Russell, Perry Shen> ;The American Surgeon. 2013 Apr 1
• 10 citations
  Reverse translation of phase I biomarker findings links the activity of angiotensin-(1-7) to repression of hypoxia inducible factor-1α in vascular sarcomas.
  W. Jeffrey Petty, Mebea Aklilu, Victor A. Varela, James Lovato, Paul D. Savage, Antonius A. Miller> ;BMC Cancer. 2012 Sep 11
• 5 citations
  Oncologic Management of Hereditary Colorectal Cancer
  George Yacoub, Srikanth Nagalla, Mebea Aklilu> ;Clinics in Colon and Rectal Surgery. 2012 Jun 1
• 72 citations
  The effect of targeted agents on outcomes in patients with brain metastases from renal cell carcinoma treated with Gamma Knife surgery
  D. Clay Cochran, Michael D. Chan, Mebea Aklilu, James Lovato, Natalie K. Alphonse, J. Daniel Bourland, James J. Urbanic, Kevin P. McMullen, Edward G. Shaw, Stephen B. ...> ;Journal of Neurosurgery. 2012 Apr 30
• 67 citations
  The current landscape of locally advanced rectal cancer.
  Mebea Aklilu, Cathy Eng> ;Nature Reviews. Clinical Oncology. 2011 Aug 9
• A dendritic cell-based vaccine effects on T-cell responses compared with a viral vector vaccine when administered to patients following resection of colorectal metasta...
  Lyerly HK, Hobeika A, Niedzwiecki D, Osada T, Marshall J, Garrett CR, Chang DZ, Aklilu M, Crocenzi TS, Cole DJ, Dessureault S, Hsu SD, Bulusu A, Clary BM, Annechiarico...> ;J. Clin. Oncol.. 2011-05-20
• A comparison of patient characteristics and outcomes in elderly compared to younger patients with esophageal cancer (EC).
  Watson GT, Russell GB, Klepin HD, Levine EA, Monjazeb A, Mishra G, Blackstock AW, Aklilu M> ;J. Clin. Oncol.. 2011-05-20
• Survival rates among patients vaccinated following resection of colorectal cancer metastases in a phase II randomized study compared with contemporary controls.
  Morse M, Niedzwiecki D, Marshall J, Garrett CR, Chang DZ, Aklilu M, Crocenzi TS, Cole DJ, Dessureault S, Hobeika A, Osada T, Clary BM, Hsu SD, Devi G, Bulusu A, Annech...> ;J. Clin. Oncol.. 2011-05-20
• 22 citations
  A Phase II study of Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in the Treatment of Metastatic Colorectal Cancer
  Nan Soon Wong, N. Fernando, Andrew B. Nixon, Stephanie M. Cushman, Mebea Aklilu, Johanna C. Bendell, Michael A. Morse, Gerard C. Blobe, Jill Ashton, Herbert Pang, Herb...> ;Anticancer Research. 2011 Jan 1
• Aprepitant/5HT-3 antagonist (EMEND) for the prevention of chemoradiation-induced nausea and vomiting (CRINV) in patients receiving gemcitabine/ 5-FU-based chemoradiati...
  Blackstock AW, Aklilu M, Lovato J, Degrass L, Sommer J, Howerton R, Mishra G, Levine E, McQuellon R> ;J. Clin. Oncol.. 2009-05-20
• 35 citations
  Arsenic trioxide in patients with adenocarcinoma of the pancreas refractory to gemcitabine: a phase II trial of the University of Chicago Phase II Consortium.
  Hedy L. Kindler, Mebea Aklilu, Sreenivasa Nattam, Everett E. Vokes> ;American Journal of Clinical Oncology. 2008 Dec 1
• Initial results of a phase II study of oxaliplatin (OX), capecitabine (CAP), bevacizumab (BV), and cetuximab (CET) in the treatment of metastatic colorectal cancer (mC...
  Bendell JC, Uronis HE, Morse MA, Blobe G, Aklilu M, Nixon A, Niedzweicki D, Honeycutt W, Howard L, Hurwitz H> ;J. Clin. Oncol.. 2008-05-20
• Patient interviews on hand-foot syndrome: Symptom assessment and impact on quality of life.
  Aklilu M, Anderson RT, Keating KN, O'Leary JJ> ;J. Clin. Oncol.. 2008-05-20
• 19 citations
  Targeted agents and esophageal cancer--the next step?
  Mebea Aklilu, David H. Ilson> ;Seminars in Radiation Oncology. 2007 Jan 1
• 28 citations
  A prospective evaluation of the impact of 18-F-fluoro-deoxy-D-glucose positron emission tomography staging on survival for patients with locally advanced esophageal ca...
  A. William Blackstock, M.R. Farmer, James Lovato, Girish Mishra, Susan A. Melin, Timothy E. Oaks, Mabea Aklilu, Paige B. Clark, Edward A. Levine> ;International Journal of Radiation Oncology, Biology, Physics. 2006 Feb 1
• 6 citations
  Pathologic complete response may not represent the optimal surrogate for survival after preoperative therapy for esophageal cancer
  A. William Blackstock, Mabea Aklilu, James Lovato, M.R. Farmer, Girish Mishra, Susan A. Melin, Timothy E. Oaks, Kim R. Geisinger, Edward A. Levine> ;International Journal of Gastrointestinal Cancer. 2006 Jan 1
• 9 citations
  A phase II study of active immunotherapy with PANVAC or autologous, cultured dendritic cells infected with PANVAC after complete resection of hepatic metastases of col...
  Emil Lou, John L. Marshall, Mebea Aklilu, David J. Cole, David W. Chang, Michael A. Morse> ;Clinical Colorectal Cancer. 2006 Jan 1
• Questions without answers.
  Frank M. Torti, Mebea Aklilu> ;Current Opinion in Oncology. 2005 May 1
• Join now to see all